Noninvasive imaging-based machine learning algorithm to identify progressive disease in advanced hepatocellular carcinoma receiving second-line systemic therapy

The aim of this study was to predict tyrosine kinase inhibitors (TKI) plus anti-PD-1 antibodies (TKI-PD-1) efficacy as second-line treatment in advanced hepatocellular carcinoma (HCC) using radiomics analysis. From November 2018 to November 2019, a total of 55 patients were included. Radiomic featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wei, Ji, Ye, Pi, Shan, Chen, Qi-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314898/
https://www.ncbi.nlm.nih.gov/pubmed/37393336
http://dx.doi.org/10.1038/s41598-023-37862-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314898/
https://www.ncbi.nlm.nih.gov/pubmed/37393336
http://dx.doi.org/10.1038/s41598-023-37862-y

Ejemplares similares